Alfa Cytology Launches Innovative Bladder Cancer Therapeutic Antibody Development Services
December 9, 2024Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research. Hauppauge, NY, United States, 9th Dec 2024 —Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services…